Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the efficacy and tolerance of 2 years of
treatment with cholecalciferol (vitamin D3) in patients with a clinically isolated syndrome
at high risk for MS (CIS).
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins